Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6017.00 | 5870.50 | 1.0250 | 1.0699 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 4154.00 | 5870.50 | 0.7076 | 0.2350 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5849.00 | 5870.50 | 0.9963 | 0.9898 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 3570.27 | 6068.00 | 5870.50 | 1.0336 | 1.0944 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5939.00 | 5870.50 | 1.0117 | 1.0326 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 6007.00 | 5870.50 | 1.0233 | 1.0651 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3620.00 | 5870.50 | 0.6166 | 0.0195 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5592.00 | 5870.50 | 0.9526 | 0.8690 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3105.00 | 5870.50 | 0.5289 | -0.1769 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3019.00 | 5870.50 | 0.5143 | -0.2085 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 5776.00 | 5870.50 | 0.9839 | 0.9553 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5833.00 | 5870.50 | 0.9936 | 0.9822 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3140.00 | 5870.50 | 0.5349 | -0.1639 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 5103.00 | 5870.50 | 0.8693 | 0.6452 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 3570.27 | 6002.00 | 5870.50 | 1.0224 | 1.0627 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4275.00 | 5870.50 | 0.7282 | 0.2854 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5959.00 | 5870.50 | 1.0151 | 1.0421 | |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 294.00 | 347.75 | 0.8454 | 0.8640 | |
| Hs 578T | 17-AAG | 3.1623 | uM | 10 | 156.25 | 66.59 | 61.00 | 347.75 | 0.1754 | -0.0361 |
| Hs 578T | Erlotinib | 0.01 | uM | 10 | 156.25 | 66.59 | 263.00 | 347.75 | 0.7563 | 0.7789 |
| Hs 578T | Linsitinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 340.00 | 347.75 | 0.9777 | 0.9812 |
| Hs 578T | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 66.59 | 335.00 | 347.75 | 0.9633 | 0.9689 |
| Hs 578T | Lapatinib | 10 | uM | 10 | 156.25 | 66.59 | 99.00 | 347.75 | 0.2847 | 0.1809 |
| Hs 578T | Linsitinib | 0.0033113 | uM | 10 | 156.25 | 66.59 | 386.00 | 347.75 | 1.1100 | 1.0895 |
| Hs 578T | Erlotinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 244.00 | 347.75 | 0.7017 | 0.7239 |